Furthermore, high expression of TTK, CDK2, and CHEK1 has been reported in ACC, which may play an important role in ACC progression and serve as potential biomarkers for future diagnosis and treatment.28–30 In summary, these miRNAs and kinases may serve as potential therapeutic targets for ACC. Here, CDK2 is linked to adrenal cortex carcinoma.